Dr. Ronald Leopold discusses implementation of pharmacogenomic screening in the healthcare industry. The conversation explores barriers to pharmacogenomic (PGx) program adoption, the future of precision medicine, and a paradigm shift away from reimbursement to value-based healthcare.
Audio PlayerFor the best experience using our website, we recommend that you upgrade to a newer version or use another web browser. A list of the most popular web browsers can be found below.
Click on an icon below to go to the download page or close this notice to continue with the current experience.